Hoechst Pakistan Limited (HPL)

PHARMACEUTICALSALLSHRKMIALLSHR

4023.98

+0.00%

As of 25-Aug-2026

52 Week RangeCurrent: 4023.98

3602.004889.99

Updated: 25-Aug-2026

1M-0.5%

3M+0.3%

1Y+11.8%

3Y+476.9%

5Y+395.4%

Valuation Snapshot

Review how the market has valued this company across price multiples.

Updated through 21-Aug-2026

P/E

10.26x

P/B

4.51x

P/S

1.23x

EV/Sales

4.05x

EV/EBITDA

17.87x

Showing 34 observations

Annual Ratio Highlights

Metric	2021	2022	2023	2024	2025
EPS	93.93	17.29	37.41	192.56	301.67
DPS	30.00	0.00	30.01	134.96	240.00
BVPS	541.39	521.78	567.53	706.85	850.93
PER	42.62x	231.52x	107.00x	20.79x	13.27x
Div Yield	0.75%	0.00%	0.75%	3.37%	6.00%
PBV	7.39	7.67	7.05	5.66	4.70
EV/Sales	2.39x	2.11x	1.76x	1.47x	1.22x
Price/Sales	2.43x	2.08x	1.81x	1.44x	1.25x
EV/EBITDA	18.85x	21.82x	15.79x	9.10x	6.17x
EV/Gross Profit	9.22x	8.03x	6.80x	4.68x	3.34x

Metric	2021	2022	2023	2024	2025
Gross Margin	25.96%	26.24%	25.86%	31.51%	36.53%
EBITDA Margin	12.69%	9.66%	11.14%	16.20%	19.74%
Operating Margin	10.57%	8.11%	9.66%	15.05%	18.60%
Pretax Margin	9.04%	3.90%	4.29%	13.01%	16.05%
Net Margin	5.70%	0.90%	1.69%	6.94%	9.41%

Metric	2021	2022	2023	2024	2025
ROE	18.53%	3.26%	6.88%	30.23%	38.76%
ROA	10.11%	1.55%	3.25%	15.85%	20.74%
ROTA	18.73%	13.94%	18.60%	34.36%	41.00%
ROCE	31.85%	29.69%	37.74%	57.30%	68.39%